MiniMed to Announce Its Fiscal Year 2027 First Quarter Financial Results
Rhea-AI Summary
MiniMed (Nasdaq: MMED) announced it expects to report fiscal year 2027 first quarter financial results on Tuesday, September 1, 2026, covering the quarter ended July 31, 2026. A summary news release is expected around 3:45 a.m. PDT, followed by a webcast from 5:45 to 6:30 a.m. PDT, with replay and transcript available within 24 hours on the company’s investor website.
Positive
- None.
Negative
- None.
News Market Reaction – MMED
In the Jul 20 session, MMED declined 0.06%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 13 | Earnings date | Neutral | +5.7% | Prior earnings-date scheduling announcement preceded a 5.7% 24-hour share-price gain. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
The prior tag-specific earnings-date announcement was followed by a 5.7% 24-hour gain.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- A news release containing summary financial information is expected at approximately 3:45 a.m. Pacific Daylight Time (PDT) and will be available at https://news.minimed.com.
- A webcast discussing results is expected be held from 5:45 to 6:30 a.m. PDT, accessible at https://investors.minimed.com.
- A replay of the webcast and transcript of the prepared remarks is expected to be available within 24 hours of the webcast by clicking on the Events link at https://investors.minimed.com.
About MiniMed
MiniMed is a global leader in insulin delivery, constantly advancing therapies that support people with diabetes in more than 80 countries. Our full-stack, integrated ecosystem, including our insulin delivery systems, CGMs, algorithms, and easy-to-use app experience, is designed to work seamlessly together, supported by white-glove, wrap-around service. For over 40 years, we've pioneered therapies people can rely on by anticipating needs, reducing burden, and helping make life with diabetes easier. Our mission is to make every day a better day for people with diabetes.
Any forward-looking statements are subject to risks and uncertainties such as those described in MiniMed's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
View original content to download multimedia:https://www.prnewswire.com/news-releases/minimed-to-announce-its-fiscal-year-2027-first-quarter-financial-results-302829078.html
SOURCE MiniMed